# ANALYSIS: OpenAI delays its IPO to 2027 — the $852 billion company that cannot go public yet

> OpenAI is currently valued at $852 billion. It is the fastest-growing software company in history, having reached $24 billion in annualized revenue in early 2026 — a figure that would place it among the most valuable public companies in the world if it listed today. And yet, in June 2026, the company confirmed what market analysts and prediction platform Kalshi had already pric

- Author: Maxime Marquette
- Publisher: MadMax (https://mad-max.co)
- Section: Analysis
- Published: 2026-06-27
- Canonical URL: https://mad-max.co/en/article/analyse-openai-repousse-son-ipo-a-2027-le-geant-qui-a-peur-de-son-propre-miroir

## Introduction: The most anticipated IPO in tech history keeps waiting

### A $852 billion company with a delay problem

**OpenAI** is currently valued at **$852 billion**. It is the fastest-growing software company in history, having reached **$24 billion in annualized revenue** in early **2026** — a figure that would place it among the most valuable public companies in the world if it listed today. And yet, in **June 2026**, the company confirmed what market analysts and prediction platform **Kalshi** had already priced in: the long-anticipated **IPO will not happen in 2026**. The target has shifted to **2027** at the earliest. **SoftBank**, one of the company's largest investors, saw its shares tumble **11 to 13 percent** on the news. The most anticipated public offering in technology history is, once again, deferred.

The delay is not a sign of weakness — not exactly. It is the product of a specific set of structural complications that are, in their own way, more revealing about the nature of **OpenAI** than a successful IPO would be. The obstacles are legal, regulatory, financial, and existential all at once. They include a sprawling lawsuit from a former co-founder, a government vetting process that has slowed the rollout of the company's most powerful model, a corporate restructuring of historic complexity, and a loss profile that would test the patience of any public market investor. Understanding why **OpenAI** cannot go public yet is understanding what **OpenAI** actually is.

### The broader market context: tech IPOs in a complicated moment

The **2026** IPO market has been uneven. Interest rate uncertainty, inflation concerns, and geopolitical tensions have made institutional investors cautious about large-scale, high-multiple technology offerings. The window for mega-cap tech listings that existed in **2021** — when almost anything with hypergrowth could achieve a successful public offering at extraordinary multiples — has narrowed considerably. **OpenAI**'s decision to delay is therefore partly a reflection of external market conditions, not only of its internal structural complexity. But the internal issues are real and would exist regardless of market conditions. Separating them is essential to understanding what would actually need to change for a **2027** listing to be achievable.

The timing matters because of what is at stake for the company's investor base. **SoftBank**'s **Vision Fund** has committed billions to **OpenAI** at valuations that require a successful public offering to generate returns. **Microsoft**, the company's largest corporate partner, has a complex commercial and equity relationship with **OpenAI** that is also affected by listing timing. Smaller investors who participated in recent private rounds at high valuations are watching the clock. Every month of delay is a month of capital locked at a valuation that has not yet been market-tested. The pressure to find a path to public markets is real — and it is mounting.

*There is something almost poetic about the situation **OpenAI** finds itself in. It has achieved the most remarkable product adoption in the history of enterprise software. It has generated more revenue, more quickly, than almost any company in history. And it is, simultaneously, unable to do what most successful companies eventually do: go public, let the market validate the valuation, and give its investors liquidity. The reasons why it cannot are a window into the contradictions at the heart of this company — and of the entire **AI** industry.*

## The corporate structure problem: when a non-profit built a trillion-dollar company

### The Public Benefit Corporation transition and its complications

**OpenAI**'s origins as a non-profit organization — founded in **2015** with explicit commitments to developing artificial general intelligence for the benefit of humanity — have created structural complications that no amount of legal creativity can fully resolve. The company's attempt to transition its commercial operations into a **Public Benefit Corporation** (**PBC**) structure has been the defining corporate governance challenge of its recent history. A **PBC** must formally balance profit-making with a public benefit purpose — a legal structure that is well-suited to companies with modest stakeholder complexity but that creates genuine difficulties for a company trying to satisfy venture capital investors, a non-profit parent organization, a $2.9 billion-plus commitment to **Microsoft**, and a public listing at an **$852 billion** valuation simultaneously.

The non-profit entity that was **OpenAI's** original legal home retains significant governance influence over the commercial entity, and the terms of its transition — how much of the PBC's value will flow back to the non-profit's charitable mission versus to commercial investors — have been contested and are still being finalized. This is not a trivial accounting issue. The resolution of this governance question will determine who actually owns the economic upside of the most valuable private company in the world. Regulators, including the **California Attorney General**, have been involved in reviewing the terms of the transition. Until this is resolved, a public offering is structurally impossible.

### The Microsoft relationship: partner, investor, and complication

**Microsoft** has invested approximately **$13 billion** in **OpenAI** and integrated **OpenAI** technology into its **Azure** cloud platform and its **Copilot** suite across **Microsoft 365**. This relationship is commercially central to both companies — **OpenAI** depends on **Azure** for its computational infrastructure, and **Microsoft** depends on **OpenAI** technology for its most strategic product differentiation. But the relationship also creates complexity in the IPO process: the terms of **Microsoft's** equity stake, revenue-sharing arrangements, and exclusivity provisions all need to be disclosed and structured in ways that satisfy public market disclosure requirements and investor expectations. Renegotiating or restructuring any aspect of this relationship to make the IPO cleaner is itself a complex and time-consuming process.

There is also a subtler tension: a publicly listed **OpenAI** would have fiduciary duties to its public shareholders that could, in theory, conflict with the commercial interests of **Microsoft** as a corporate partner. Public shareholders might prefer **OpenAI** to negotiate harder on commercial terms with **Microsoft**, or to develop competing cloud infrastructure relationships with other providers. Managing this tension — in the terms of the partnership and in the governance structure of a public company — is one of the legal and commercial puzzles that the IPO preparation process must solve before listing becomes viable.

*The **Microsoft-OpenAI** relationship is one of the most strategically consequential partnerships in technology history. It is also, from a purely corporate governance standpoint, a mess. Two companies that are simultaneously partners, investors, and potential competitors, bound by agreements whose terms have evolved rapidly as **OpenAI's** valuation has grown from **$29 billion** to **$852 billion**. Untangling enough of this to produce a clean IPO prospectus is not a weekend job. It is a years-long process. And the delay reflects that reality.*

## The Elon Musk lawsuit: a legal cloud over the IPO

### The original co-founder's claims

**Elon Musk**, one of **OpenAI's** original co-founders and donors, filed a lawsuit against the company alleging that its transition to a for-profit structure violated the founding commitments he made his contributions in reliance upon. The lawsuit claims, in essence, that **OpenAI**'s original non-profit mission — to develop **AGI** for the benefit of all humanity — has been abandoned in favor of commercial objectives that benefit a small group of investors, and that this abandonment constitutes a breach of fiduciary and contractual duties. **Musk** has also separately founded **xAI**, his own artificial intelligence company, making his legal challenge a mixture of principled objection and competitive strategy — a combination that courts will need to untangle.

The lawsuit is significant for the IPO not primarily because of its legal merits — which are contested — but because of its disclosure implications. A pending material litigation involving founding-era commitments and the governance of a non-profit-to-PBC transition is precisely the type of legal cloud that public market investors and underwriters find deeply uncomfortable. An **IPO prospectus** that must disclose an unresolved multi-billion-dollar lawsuit from a co-founder alleging mission abandonment creates a narrative problem that no amount of financial performance data can fully offset. Resolving, settling, or otherwise materially advancing the litigation is a precondition for a credible IPO process.

### The regulatory scrutiny dimension

Beyond the **Musk** lawsuit, **OpenAI's** transition has attracted scrutiny from multiple regulatory bodies. The **California Attorney General's** office has reviewed the terms of the non-profit-to-PBC conversion to ensure that charitable assets are not being improperly transferred to private investors. The **Federal Trade Commission** has examined **OpenAI's** competitive practices and data policies. International regulators in the **European Union** and the **United Kingdom** have been monitoring the company's market power and compliance with **AI Act** provisions. Each of these regulatory threads requires legal resources and executive attention — and each creates potential disclosure obligations or remediation requirements that complicate the timeline for a public offering.

The accumulation of legal and regulatory challenges facing **OpenAI** is, in a sense, the price of its extraordinary success and its unconventional origins. A more conventional corporate structure would have fewer of these complications. But **OpenAI** was founded as a non-profit, grew into the world's most valuable AI company through a series of improvised structural adaptations, and is now attempting to make a transition to public markets while managing the legacy of each of those adaptations simultaneously. The legal complexity is not a distraction from the company's real story. It is a central chapter of it.

*The **Elon Musk** lawsuit is easy to dismiss as the grievance of a billionaire who left a company that then succeeded without him. But the legal question at its core — whether **OpenAI** has honored the mission that generated its initial resources and talent — is not trivial. It is a question about what we actually want from institutions that are built on public benefit commitments. I do not know whether **Musk** is right on the merits. But I think the question he is raising deserves a serious answer, not just a legal defense.*

## The loss profile: $14 billion in losses against $24 billion in revenue

### The economics of frontier AI development

**OpenAI** reported losses of approximately **$14 billion in 2025**, against revenues that reached **$24 billion in annualized terms** by early **2026**. The revenue growth is extraordinary by any standard — from near zero in **2022** to a potential **$24 billion run rate** in just three years. But the loss profile reflects the staggering cost of developing and deploying frontier AI models. Training a single iteration of a frontier model like **GPT-5** series requires compute investments that can run into the billions of dollars. Maintaining the infrastructure to serve hundreds of millions of users globally requires capital expenditure at a scale that few companies in history have faced.

The path to profitability for **OpenAI** requires either a dramatic reduction in training and inference costs — which is happening, driven by hardware improvements and algorithmic efficiency gains — or a dramatic increase in revenue from enterprise and consumer products — which is also happening, but not yet fast enough to offset the investment in the next generation of models. The company is in the classic high-growth technology company paradox: each dollar of revenue requires more than a dollar of investment in the infrastructure and model development that produces it. The question is not whether the economics will eventually work — most analysts believe they will — but whether the timeline to profitability is fast enough to satisfy public market investors at an **$852 billion** entry valuation.

### Sarah Friar's argument for delay: the case for patience

**Sarah Friar**, **OpenAI's** Chief Financial Officer, has publicly articulated the case for delaying the IPO until the company's financial profile is better suited to the demands of public markets. Her argument is essentially that the obligations of being a public company — quarterly earnings calls, short-term investor pressure, disclosure requirements that could compromise competitive strategy — would be particularly costly for **OpenAI** at its current stage of development. The company is in the middle of the largest capital expenditure cycle in its history, investing heavily in infrastructure and model development that will generate returns over a multi-year horizon. Public market investors, with their preference for quarterly predictability, are not the ideal shareholders for this phase of the business.

This argument has merit. The history of technology IPOs is littered with examples of companies that listed too early, before their business model was sufficiently developed, and whose public market experience constrained rather than enabled their growth. Amazon's early years as a public company — consistently criticized for its loss-making investment strategy — are the canonical example of a company that succeeded despite, not because of, public market pressure. **Friar's** instinct to protect **OpenAI's** strategic flexibility during its most critical investment phase is sound. The question is whether the investor base's patience — and their need for liquidity — allows for the timeline she is proposing.

*The tension at the heart of **OpenAI's** IPO dilemma is one of the most interesting in contemporary capitalism: a company that genuinely believes its mission is too important to be constrained by short-term public market pressure, trying to convince investors who gave it money precisely because they expected a path to liquidity and returns. Both positions are reasonable. Their reconciliation is the job of financial architecture — and it is, demonstrably, not yet complete.*

## GPT-5.6 and government vetting: when AI power requires security review

### Staggered rollout and the national security dimension

**OpenAI's** decision to stagger the rollout of **GPT-5.6** — subjecting it to government vetting before full public release — represents a significant evolution in the relationship between frontier AI development and national security institutions. The company has, in effect, accepted a form of pre-deployment regulatory review for its most powerful models — a precedent that has no clear equivalent in the history of commercial software. The rationale is straightforward: models at the frontier of capability have potential dual-use applications — in cybersecurity, biological research, intelligence analysis, and strategic planning — that justify a structured review process before wide deployment.

The government vetting process involves collaboration between **OpenAI** and agencies including **DARPA**, components of the **intelligence community**, and civilian regulatory bodies. The review assesses the model's capabilities against known risk categories — **CBRN** (chemical, biological, radiological, nuclear) uplift potential, cyberweapon development assistance, and mass manipulation capabilities among them. This process is not yet standardized — it is being developed in real time, through negotiation between the company and government reviewers — and its duration is variable. For the IPO, the implications are significant: a company that is subject to pre-deployment government review for its core products faces a degree of regulatory uncertainty that public market investors will need to understand and price.

### The competitive implications of vetting delays

Every week that **GPT-5.6's** rollout is delayed by government vetting is a week during which competitors — including **Anthropic**, **Google DeepMind**, and increasingly capable Chinese models like **DeepSeek V4** — continue to operate without equivalent constraints. This asymmetry creates competitive pressure that **OpenAI**'s leadership has been explicit about in private communications and has begun to address more publicly. The argument is not that national security review is inappropriate — it is that the review process needs to be faster, more transparent in its criteria, and more uniformly applied across the frontier AI industry to avoid systematically disadvantaging the most safety-conscious developers.

The competitive dynamics of frontier AI development operate on timescales of weeks and months, not the years that traditional national security review processes are designed for. The gap between the speed of AI capability development and the speed of regulatory processes is one of the defining governance challenges of the current period. **OpenAI** finds itself at the epicenter of this gap — a company that has embraced safety-oriented engagement with government institutions, but that is increasingly paying a competitive price for doing so while others move faster with less oversight. This dynamic, if it persists, creates perverse incentives in the industry — rewarding those who engage less with government review processes and penalizing those who engage more.

*The government vetting of frontier AI models is one of the most consequential and least publicly understood developments in the current **AI** landscape. I am broadly supportive of it — models capable of providing significant uplift in dangerous domains should be reviewed before wide deployment. But the review process needs to be fast enough to avoid systematically distorting the competitive landscape. A process that takes months while the industry moves in weeks is a process that will eventually be abandoned — not because of bad intentions, but because the competitive pressure becomes intolerable. Speed and rigor are both necessary. The current process may be rigorous. I am less certain it is fast enough.*

## The Anthropic competition: the IPO calculus of rivalry

### Anthropic's funding trajectory and the pressure it creates

**Anthropic**, founded in **2021** by former **OpenAI** employees including **Dario Amodei** and **Daniela Amodei**, has emerged as the most credible technical rival to **OpenAI** in the frontier AI space. The company has raised billions from investors including **Google**, **Amazon**, and **Spark Capital**, and its **Claude** model series has been widely praised for its performance on reasoning tasks and its approach to AI safety. **Anthropic's** valuation has grown rapidly, reaching over **$40 billion** by mid-**2026**, and the company has been publicly exploring its own path to public markets in the medium term.

The existence of a credible, well-funded rival has direct implications for **OpenAI's** IPO calculus. In a market where **Anthropic** is also approaching public market readiness, the first company to list captures certain benefits: primary market narrative, the valuation benchmark that subsequent listings will be measured against, and the talent and commercial momentum that a successful IPO generates. **OpenAI's** decision to delay rather than rush to market despite **Anthropic's** proximity suggests that its leadership believes the structural issues with a premature listing outweigh the competitive benefits of listing first. That is either a display of strategic discipline or of structural necessity — probably both.

### The talent war and the IPO as retention tool

In the frontier AI industry, talent is the scarcest and most contested resource. The most technically capable researchers can command packages from **OpenAI**, **Anthropic**, **Google DeepMind**, and a growing number of well-funded startups. Equity compensation — specifically, the prospect of significant liquidity from stock options vesting before or at an IPO — is a critical component of these packages. For **OpenAI**, the delay in its IPO creates a direct retention challenge: researchers and engineers who joined expecting a **2025** or **2026** liquidity event are now looking at a **2027** or later timeline. Some of them will reconsider whether to stay.

The company has attempted to manage this through secondary market transactions — allowing employees to sell some of their shares in private market trades at current valuation levels. These transactions provide partial liquidity but do not fully substitute for the scale and optionality of a public listing. The talent retention pressure created by the IPO delay is not existential — **OpenAI** remains the most prestigious employer in frontier AI — but it is real, and it is one of the less visible costs of the structural complications that have pushed the listing to **2027**.

*The talent retention dimension of the IPO delay is the one that worries me most from an industry perspective. The people building the most capable **AI** systems in the world are humans who respond to normal human incentives — including financial ones. A delay that causes some of the best researchers to leave **OpenAI** for competitors, seeking earlier liquidity, would be a cost that does not show up in any financial prospectus but that could matter more than any legal complexity for the company's long-term trajectory. The most important assets of a frontier **AI** company are not in its data centers. They are in its researchers' heads.*

## SoftBank's reaction: what an 11-13% drop tells us about investor expectations

### The Vision Fund's exposure and its implications

**SoftBank's Vision Fund** has made a series of bets on **OpenAI** that represent one of the largest concentrated exposures to a single private technology company in the fund's history. The **11 to 13 percent** decline in **SoftBank**'s shares following the IPO delay announcement reflects investor reassessment of the timeline to liquidity for this exposure. The **Vision Fund**'s model — making large bets in growth-stage companies and generating returns through IPOs or strategic sales — requires public listing events to deliver returns to its own investors. A delay to **2027** extends the capital cycle, affects internal rate of return calculations, and raises questions about what other assumptions in the **SoftBank** investment thesis might need adjustment.

The magnitude of the share price reaction — **11 to 13 percent** in a single trading session — illustrates the degree to which **SoftBank's** market valuation had already incorporated an assumption of a **2026 OpenAI IPO**. This is a familiar dynamic in technology investing: public market investors effectively front-run private market events, building positions in publicly traded investors in anticipation of liquidity events in their private portfolios. When those events are delayed, the reverse happens — positions are reduced, assumptions are repriced, and the market signals its recalibration through the share prices of the relevant listed entities.

### The broader signal for AI investment valuations

The **SoftBank** reaction is also a data point in the broader question of how public markets are likely to value **AI** companies when they eventually list. The **$852 billion** private market valuation of **OpenAI** is based on the last private funding round — a figure negotiated between the company and a small number of sophisticated investors, reflecting growth assumptions, competitive position, and a range of optimistic scenarios. Public market investors — with access to quarterly disclosure, analyst scrutiny, and the ability to sell shares at any moment — typically apply different, and often more conservative, valuation frameworks. The fact that a major public market investor (through **SoftBank**) reacted negatively to the delay suggests that the path from private to public valuation may involve more compression than **OpenAI's** leadership and private investors would prefer.

This dynamic is not specific to **OpenAI**. It is a structural feature of the current **AI** investment cycle, in which private market valuations have been inflated by competitive bidding among a relatively small number of large investors, and in which the eventual public market test may produce a more sober assessment of long-term economics. The delay of the **OpenAI IPO** to **2027** does not resolve this tension — it postpones it. When the listing eventually happens, the market will render its judgment on whether **$852 billion** was a realistic valuation for a company with **$14 billion in annual losses** and a corporate structure that is still being finalized.

*I find the **SoftBank** share price drop oddly clarifying. It cuts through the hype and reveals a simple fact: the people who have the most money invested in **OpenAI**'s success are worried. Not catastrophically — a **13 percent** decline is not a panic. But worried enough to reprice. That worry, in the language of financial markets, is worth paying attention to. It is more honest than any press release about the company's prospects.*

## The 2027 timeline: what would need to happen for it to be realistic

### The legal and structural checklist

For a **2027 OpenAI IPO** to be viable, a specific set of conditions would need to be met. The **non-profit-to-PBC transition** would need to be completed, with the terms of the charitable asset distribution agreed upon by all parties and cleared by the **California Attorney General**. The **Musk lawsuit** would need to be resolved — either through settlement, dismissal, or a court ruling — sufficiently in advance of the IPO filing to remove it as a material litigation risk. The **Microsoft** partnership terms would need to be restructured or disclosed in a way that satisfies public company requirements. And the governance documents of the new **PBC** entity would need to be finalized and defensible to institutional investors and their legal advisers.

None of these items is impossible to achieve in **twelve to eighteen months**. But each requires sustained attention, legal resources, and in some cases negotiations among parties with competing interests. The concurrence of all of them in the timeframe necessary for a **2027** listing is achievable but not guaranteed. The most likely single point of failure is the litigation — lawsuits are notoriously difficult to predict in timeline and resolution, and the **Musk** case involves parties with the resources and motivation to litigate exhaustively.

### The financial profile requirements

Beyond the legal and structural issues, a successful **2027** IPO would benefit from a materially improved financial profile. A **revenue run rate** that has continued to grow — analysts project potential revenues of **$40 to $50 billion** by **2027** — combined with a meaningful narrowing of the loss profile would make the company's economics more defensible to public market investors. The key driver of loss reduction is the declining cost of inference — serving model outputs to users — as hardware improves and algorithmic efficiency advances. If the cost curve follows the trajectory that most industry analysts project, **OpenAI's** unit economics should improve substantially by **2027**, making the path to eventual profitability more visible and more credible to investors.

The enterprise segment is also critical. **OpenAI's** consumer product — **ChatGPT** — has achieved adoption at a scale that no consumer software product in history has matched. But consumer revenue, while significant, is more volatile and lower-margin than enterprise contract revenue. The growth of **OpenAI's** enterprise business — selling **API** access and specialized models to large corporations — will be a central narrative of any **IPO** roadshow. The strength of that business in **2027** will do more than any other single factor to determine whether the public market is willing to pay a valuation approaching the current private-market figure.

*The financial profile question is ultimately the one that will determine whether the **OpenAI IPO** is a success or a disappointment — regardless of the legal and structural issues. A company growing revenues at triple-digit rates while narrowing its losses is a story that public market investors can get behind, even at a high entry valuation. A company still burning **$14 billion a year** at the time of listing is a much harder story to tell. The next eighteen months of financial results are, in many ways, the IPO.*

## The artificial intelligence industry's IPO moment: a broader picture

### OpenAI in the context of a wave of AI listings

**OpenAI** is not the only **AI** company approaching public markets. **Anthropic**, **Cohere**, **Mistral**, and a range of application-layer **AI** companies are at various stages of IPO preparation. The first few major **AI** infrastructure listings will set the valuation framework — the multiples of revenue, the discount to addressable market — that subsequent listings are measured against. **OpenAI's** delay means it may not be the first major frontier **AI** company to list. That carries both risk and opportunity: the risk is that a first-mover competitor sets an unfavorable valuation framework; the opportunity is that early listings allow **OpenAI** to observe what works and what fails in the first round of **AI** IPO narratives.

The broader wave of **AI** listings will also test a fundamental question about the industry's economics: are the extraordinary valuations of private **AI** companies supportable in public markets, where investors have access to complete financial disclosures and can compare performance against stated projections? The answer to that question — which will emerge from the first major **AI** IPO wave — will shape investment in the entire industry for years. **OpenAI's** listing, when it eventually happens, will be the most important data point in that test.

### The global regulatory context: AI governance as an IPO risk factor

The global regulatory environment for artificial intelligence is evolving rapidly and unpredictably. The **EU AI Act**, the **US AI Executive Order**, emerging frameworks in the **UK**, **Japan**, and **India** — all of these create regulatory uncertainty that an IPO prospectus must disclose as a material risk factor. For **OpenAI** specifically, the risk profile is unusual: as the developer of the world's most capable and widely deployed **AI** models, it is simultaneously the most prominent target of **AI** regulation and the company with the most to lose from regulatory restrictions on AI capabilities or deployment.

The relationship between **OpenAI** and government institutions has evolved significantly. The company's decision to submit its models to government vetting before deployment — and its active engagement in policy discussions about AI governance — reflects a calculation that proactive cooperation with regulatory institutions reduces the risk of more restrictive imposed regulation. This is a defensible strategy. But it creates a form of regulatory dependency — the company's product development timeline is partly determined by government review processes — that public market investors will need to understand and evaluate. Adding **AI regulation risk** to the existing legal and structural complications is one more item on the list of reasons why the **2027** timeline is achievable but challenging.

*The regulatory risk section of the eventual **OpenAI** IPO prospectus will be one of the most extraordinary documents in the history of technology finance. A company that is simultaneously the most regulated, the most strategically important, the most legally contested, and the most financially extraordinary in its sector — the list of material risk factors will require careful reading. I genuinely look forward to it. It will tell us more about what **OpenAI** actually is than any interview with its CEO.*

## What the delay means for the broader AI landscape

### Signal effects on funding and competition

The announcement that **OpenAI's** IPO is delayed to **2027** sends signals through the broader **AI** investment ecosystem. For venture capital firms with significant **AI** portfolios, it extends the horizon for liquidity events across the sector. It also potentially reduces the urgency for competing firms to rush to public markets — if **OpenAI**, with its extraordinary revenue growth and brand recognition, is not ready to list, the case for smaller companies listing earlier becomes more difficult to make. The delay may, paradoxically, extend the private market phase of the AI investment cycle — keeping more capital concentrated in private companies for longer, and continuing to support private market valuations that have not yet been subjected to public market scrutiny.

For competitors, the delay creates a window. **Anthropic**, in particular, might consider whether a path to public markets ahead of **OpenAI** — if the structural challenges at **OpenAI** extend the delay further — could provide a first-mover advantage in the public market narrative. **Google DeepMind**, operating as a division of **Alphabet**, is already effectively public. **Meta AI** similarly. The frontier **AI** landscape is becoming a competition between public companies with established public market relationships and private companies still resolving the structural prerequisites for listing.

### The geopolitical dimension: AI leadership and capital markets

There is a geopolitical dimension to the **OpenAI IPO** story that is rarely made explicit. The ability of American frontier **AI** companies to access public capital markets efficiently — to convert their technological leadership into market capitalization that funds further research and development — is part of the competitive advantage that the **United States** holds in the global **AI** race. A prolonged private market phase, while **Chinese AI** companies like **Baidu**, **Alibaba**, and others are actively accessing capital through different mechanisms, is not a crisis — but it is a friction. The faster **OpenAI** can convert its technology leadership into public market capital, the more resources it has to maintain that leadership against increasingly capable international competitors.

This framing — **AI** company IPOs as instruments of strategic competition — is not how most financial analysts think about the subject. But it is how some in the national security and strategic competition community are beginning to think about it. The delay to **2027** is, from this perspective, not just a corporate finance story. It is a small but meaningful friction in the machinery of American technological competitiveness. Not decisive. But not irrelevant.

*I am consistently struck by how few people make the connection between capital markets efficiency and technological competitiveness. The ability to raise capital quickly, cheaply, and at scale from public markets is one of the structural advantages that American technology companies have long enjoyed. Anything that slows that process — legal disputes, structural complexity, regulatory uncertainty — is, at the margin, a competitive disadvantage. Not relative to a specific competitor, but relative to the theoretical speed of development that full capital access would enable. The IPO delay is a small tax on **American AI** leadership. Small. But worth naming.*

## The path to 2027: a strategic assessment

### The most likely scenario

The most likely scenario, given the available information, is that **OpenAI** will list in **2027** — probably in the second or third quarter — assuming that the legal and structural prerequisites are met on schedule. The **PBC transition** will be completed, the **Musk litigation** will be settled or substantially resolved, the **Microsoft** relationship terms will be restructured for public company requirements, and the company's revenue will have grown to a level that makes the loss profile more defensible. The IPO will not be the clean, enthusiastic event that a company with simpler origins might achieve — but it will happen, and it will price at a valuation that reflects both the extraordinary strength of the business and the legitimate questions about its structure, governance, and path to profitability.

The more pessimistic scenario — a delay beyond **2027**, driven by unresolved litigation or deteriorating financial conditions — is possible but unlikely given the company's revenue trajectory and the pressure for liquidity from its investor base. The more optimistic scenario — a successful late-**2026** listing if legal issues are resolved faster than expected — is also possible, though the structural complexity makes it improbable. **2027** remains the central case, with meaningful uncertainty on both sides. What is certain is that when **OpenAI** eventually lists, it will be one of the most consequential market events of the decade — a test of whether public markets can accurately value the most transformative technology company of the current generation.

### What success would look like

A successful **OpenAI IPO** would look like this: a company with **$40-plus billion in annualized revenue**, a loss that has narrowed meaningfully from its **2025** peak, a corporate structure that is clean enough for institutional investors to hold comfortably, a litigation profile that is manageable rather than threatening, and a market narrative that convincingly explains the path from the current investment phase to sustainable profitability. It would price at a valuation that, while lower than the current private market figure, still represents a premium to comparable public technology companies — justified by the company's unique competitive position and the scale of its addressable market.

That outcome is achievable. The distance between the current situation and that outcome is measured in legal work, financial progress, and structural decisions that are all within the control of people at **OpenAI** and its investors. The delay to **2027** is frustrating for those waiting for liquidity. But it may ultimately serve the company's long-term interests — and the long-term interests of public market investors who will own it — better than a premature listing at a moment of structural complexity would have. Patience, in this case, is not weakness. It is the correct strategic judgment.

*I have covered enough corporate stories to know that the companies most celebrated at their IPO are not always the ones that deliver the best long-term returns. And the companies that delay until their fundamentals are genuinely strong often list with less fanfare but perform better over time. **OpenAI's** leadership is betting that patience will produce a better outcome than speed. They may be right. I hope they are. Because the alternative — a high-profile IPO that disappoints public markets — would do damage not just to the company, but to the entire narrative of **AI** as a transformative technology.*

## The impact on the AI startup ecosystem

### The signal effect for investors

The delay of **OpenAI**'s IPO to **2027** sends an ambivalent signal across the entire artificial intelligence startup ecosystem. On one hand, it signals that even the sector's most valued company hesitates to face public markets — which discourages earlier-stage AI startups from rushing their own path to listing. On the other, it confirms the considerable appeal that **OpenAI** holds for institutional investors waiting to buy public exposure to the generative AI sector.

Venture capital funds that have invested heavily in AI — **Andreessen Horowitz**, **Sequoia**, **Khosla Ventures** — need liquidity for their own investors. Every month of delay by **OpenAI** is another month those funds cannot demonstrate the return on their bets. This cascading pressure affects the valuations of every AI startup in their portfolios. **In the venture capital ecosystem, the IPO of a locomotive like OpenAI opens or closes doors for dozens of other companies in the sector.**

### The acceleration of consolidation

A market where large IPOs are slow to arrive generally favors consolidation: the strongest players acquire the weaker ones before public markets can serve as arbiters. In AI, this consolidation is already visible — **Microsoft** has deepened its ties with **OpenAI**, **Amazon** has taken a stake in **Anthropic**, **Google** has absorbed entire teams. The delay in **OpenAI**'s IPO could accelerate this movement. Second-tier AI startups, whose investors are waiting for liquidity, may become more open to acquisitions or mergers.

For the sector's competitive dynamics, this consolidation carries significant implications. A market where two or three giants — **OpenAI**, **Anthropic**, **Google DeepMind** — completely dominate presents different risks than a market with many independent players. The concentration of computing resources, training data, and talent in a few hands raises governance and competition questions that neither regulators nor markets have yet genuinely addressed. **OpenAI**'s IPO, when it arrives, could accelerate a consolidation whose implications reach well beyond the technology sector alone.

*The consolidation of the AI sector around a handful of major players worries me beyond the financial stakes. When a technology as foundational as generative AI is controlled by two or three private companies — however innovative and well-intentioned they may be — the questions of governance, access, and democratic accountability become urgent. The IPO is not merely a market event. It is a governance moment.*

## The stakes of post-IPO financial transparency

### What public markets will reveal

When **OpenAI** lists, the transparency requirements of public markets will compel the company to disclose detailed financial information that private investors currently access only in part. The confidential **S-1** filed in June 2026 will be made public before listing — and with it will come precise data on revenues by segment, infrastructure costs, agreements with major clients, ongoing litigation, and risks identified by management.

These disclosures could surprise in either direction. Better-than-expected data — if developer **API** revenues are more solid than public estimates, or if enterprise agreements have already secured significant recurring revenue — would reinforce the trillion-dollar investment thesis. Disappointing data — even higher infrastructure costs, elevated churn rates among **ChatGPT** subscribers, significant contractual concessions granted to **Microsoft** — could revise expectations downward. **OpenAI**'s S-1 will be the most analyzed technology document of the decade.

### PBC governance under the public spotlight

The **Public Benefit Corporation** structure of **OpenAI** will face unprecedented scrutiny once the company is public. Shareholders will have a legal right to challenge board decisions if they believe commercial interests are not balanced against the public benefit mission. Conversely, activist shareholders could argue that certain fundamental research decisions — such as investments in projects with a ten-plus-year return horizon — do not sufficiently serve shareholders.

The tension between the mission of "building AGI for the benefit of humanity" and the demands of quarterly returns will be permanent and public. It will fuel articles, analyses, analyst reports, and potentially activist shareholders. **Sam Altman**, who currently navigates the relatively sheltered waters of a private company, will have to manage that tension in front of the cameras and microphones of Wall Street. That is a governance challenge of a fundamentally different nature from researching AGI. **The IPO will transform OpenAI's leadership as much as its balance sheet.**

*The financial transparency that the OpenAI IPO will impose is a good thing for society, not just for shareholders. When a company as influential as **OpenAI** is private, decisions about what it develops, how it deploys it, what risks it takes — all of that happens away from any public scrutiny. Listing on a stock exchange is not a governance ideal, but it is a beginning of accountability.*

## Generative AI and the transformation of the labor market

### The question nobody wants to ask at the IPO

There is a question that the investment bankers preparing **OpenAI**'s IPO roadshow do not ask: **how fast is generative AI destroying jobs?** The question is politically sensitive, but economically central to evaluating the investment thesis. If **OpenAI** generates its revenues by helping companies automate intellectual tasks — writing, analysis, coding, customer service — then its best clients are precisely those reducing their payroll through its products.

This dynamic creates a paradox: **the more commercially successful OpenAI becomes, the more it accelerates a labor market transformation that will require significant policy responses** — continuous retraining, social protection, sharing of productivity gains. Those social costs will be paid collectively, not by **OpenAI**. It is a negative externality that financial analysts' valuation models typically do not incorporate. For public markets, which value on direct financial metrics, this social dimension is invisible. But for the regulators and governments who will have to manage the transition, it will not remain invisible for long.

### AI regulation: the risk that markets underestimate

The **European Union** adopted the **AI Act** in 2024, which is progressively entering into force. This regulatory framework classifies AI systems by risk level and imposes specific obligations — including transparency, documentation, and audit requirements — on general-purpose AI models like those of **OpenAI**. Compliance with the European AI Act represents a real operational cost for **OpenAI** and its competitors. Similar regulations are emerging in the **United States**, the **United Kingdom**, and **Japan**.

For **OpenAI**'s IPO, the regulatory risk is real and growing. The S-1 will need to identify risks tied to existing and emerging regulations across each key market. Institutional investors, familiar with heavily regulated sectors like finance and pharmaceuticals, will factor this risk into their valuations. **A company that today operates with few regulatory constraints could, in ten years, function in an environment as constrained as that of systemic banks.** The price of that eventual transition is not yet in the models.

*The impact of AI on employment is the conversation that the technology industry carefully avoids during its IPO roadshows. I understand why — it is not a good conversation for selling shares. But it is the conversation our societies must have now, before the transition is already complete. After the fact, it will be too late to plan.*

## Conclusion: when the most valuable private company in the world is not ready for the public

### The paradox of extraordinary success and unresolved structure

The **OpenAI** IPO delay is, in the end, a story about the gap between achievement and institutional readiness. The company has achieved something genuinely unprecedented — building the most capable and most widely adopted **AI** systems in history, at a speed and scale that no previous technology company has approached. Its financial metrics are extraordinary. Its product adoption is unmatched. And yet it is not ready to go public — not because of any failure in its core business, but because the institutional structures necessary to support a public company have not kept pace with the growth of the business itself. That gap is being closed. But it is not yet closed enough.

The **2027** target is not a deferral of ambition. It is a recognition of the complexity of what **OpenAI** is trying to do: create a commercially successful technology company that also honors a founding commitment to beneficial **AI** development, satisfies investors who need returns, operates under government oversight that is still being designed in real time, and competes in a market moving faster than any regulatory framework can track. That is an extraordinary number of competing obligations. Meeting them well — rather than rushing to market before they are resolved — is the right choice. Even if it costs **SoftBank** some points in a single trading session.

### The long view

The most important question about the **OpenAI IPO** is not whether it happens in **2026** or **2027**. It is whether, when it does happen, the company has resolved the structural and governance questions in a way that sets it up for a durable public company existence — rather than a spectacular listing followed by the kinds of internal contradictions that have derailed other technology companies that went public before they were ready. The delay, however frustrating for investors in the short term, serves that longer-term objective. The companies that last are the ones that build their foundations carefully — even when the temptation to move faster is enormous. **OpenAI**, for all its extraordinary speed in technology development, is being appropriately patient with its corporate architecture. That is the right call.

*I end this analysis with a question that I think is more important than the IPO timing: what kind of company does **OpenAI** want to be in twenty years? The answer to that question — about mission, governance, accountability, and the balance between commercial success and public benefit — will determine whether the eventual IPO is just a financial event or something more meaningful: the moment when the most consequential technology company of our era makes a lasting commitment to public accountability. That would be worth waiting for. Even if it takes until **2027**.*

**By Maxime Marquette, columnist**

## Columnist's transparency note

### Editorial stance

I am not a journalist but a **columnist and analyst**. My expertise lies in observing and analysing the geopolitical, economic and strategic dynamics that shape our world. My work is to take political strategies apart, to understand global economic movements, to put the decisions of international actors in context and to offer analytical perspectives on the changes that are redefining our societies.

I do not claim the cold objectivity of traditional journalism, which stops at reporting facts. **I claim analytical clarity**, rigorous interpretation and a deep understanding of the complex issues that concern us all. My role is to give meaning to the facts, to place them in their historical and strategic context, and to offer a critical reading of events.

### Method and sources

This text keeps the basic distinction between **verified facts and interpretive analysis**. The rule never changes: a factual claim is published only when a verifiable source supports it, and the sources this article actually used are listed under **Sources**, never here.

**Primary source families** used by the publication, when the story has them: official statements from governments and international institutions, public statements by political leaders, reports from intergovernmental organisations, dispatches from recognised international news agencies.

**Secondary source families**: specialised publications, internationally recognised news media, analyses from established research institutions, reports from industry organisations.

When an article cites statistical, economic or geopolitical data, it comes from the institutions that produce it (intergovernmental organisations, central banks, national statistics offices), and the exact institution is named under **Sources**.

### Nature of the analysis

The analyses, interpretations and perspectives in the analytical sections of this article are a **critical, contextual synthesis** based on the information available, the trends observed and the expert comments cited in the sources consulted.

My role is to interpret these facts, to set them in the context of today's geopolitical and economic dynamics, and to give them a coherent meaning within the larger story of the changes shaping our time. These analyses reflect expertise built through continuous observation of international affairs and an understanding of the strategic mechanisms that drive global actors.

This article describes a documented state of affairs on its publication date, not a prediction: later developments may shift its outlook. No update is promised in advance; when an article is corrected or completed, the change is dated in the text.

## Sources

### Primary sources

- [CNBC — OpenAI IPO timeline delayed: Kalshi prediction market signals 2027 at earliest — June 26, 2026](https://www.cnbc.com/2026/06/26/openai-ipo-timeline-delayed-kalshi-predictions.html)

- [SiliconAngle — OpenAI staggers GPT-5.6 rollout amid government vetting, eyes 2027 IPO — June 25, 2026](https://siliconangle.com/2026/06/25/openai-staggers-gpt-5-6-rollout-government-vetting-eyes-2027-ipo/)

- [Bloomberg — SoftBank shares tumble after report of OpenAI's IPO delay — June 26, 2026](https://www.bloomberg.com/news/articles/2026-06-26/softbank-s-shares-tumble-after-report-of-openai-s-ipo-delay)

### Secondary sources

- Foreign Policy — OpenAI's IPO delay and the geopolitics of AI investment — June 2026

- [Euromaidan Press — What OpenAI's IPO delay means for the global AI industry — June 2026](https://euromaidanpress.com/2026/06/openai-ipo-ai-industry-public-markets/)

- The Guardian — OpenAI delays IPO plans to 2027 as SoftBank shares fall — June 2026

---

Source: Maxime Marquette, MadMax. When citing, name the author and link https://mad-max.co/en/article/analyse-openai-repousse-son-ipo-a-2027-le-geant-qui-a-peur-de-son-propre-miroir